A detailed history of Envestnet Asset Management Inc transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 28,355 shares of PRME stock, worth $82,229. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,355
Previous 21,660 30.91%
Holding current value
$82,229
Previous $111,000 1.8%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$3.41 - $6.7 $22,829 - $44,856
6,695 Added 30.91%
28,355 $109,000
Q2 2024

Aug 08, 2024

SELL
$4.3 - $8.03 $5,246 - $9,796
-1,220 Reduced 5.33%
21,660 $111,000
Q1 2024

May 13, 2024

BUY
$6.35 - $9.39 $3,238 - $4,788
510 Added 2.28%
22,880 $160,000
Q4 2023

Feb 13, 2024

BUY
$5.59 - $9.55 $32,164 - $54,950
5,754 Added 34.63%
22,370 $198,000
Q3 2023

Nov 13, 2023

BUY
$9.5 - $15.07 $157,852 - $250,403
16,616 New
16,616 $158,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $278M
More about PRME
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.